Publication | Closed Access

Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

First Line ChemotherapyMedicineClinical EndpointGynecologyCancer TreatmentOncologyRadiation OncologyRecurrent Endometrial CarcinomaGynecology OncologyLate-breaking Abstract 1